PTCy versus ATG in HLA-matched sibling donor allogeneic transplantation: Comment on: Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party

请注册登录后继续浏览